Department of Pharmacology Tea Club
Tea Club will be held as usual in the Departmental Lecture Theatre at 4 pm on Fridays in Full Term. After the talk there will be wine and nibbles and a chance to talk informally with the speaker. If anyone wishes to have some time with any speaker before the talk, or have dinner with them afterwards, please contact Dr Taufiq Rahman in advance.
Department of Pharmacology Virtual Tea Club
Lent 2021 (4 pm Friday)
22nd January
Ritwick Sawarkar Chromatin response to SARS CoV-2 infection identifies a therapeutic target
MRC Toxicology Unit, University of Cambridge
29th January
Maria Marti System-specific isoform expression as a physiological driver of GPCR signalling bias
LMB, Cambridge
5th February
Angela Russell Discovery of Small Molecules to Manipulate Cell Fate In Vivo: Towards New Therapies for Degenerative Diseases
Department of Chemistry, University of Oxford
12th February
Sarah Ross Oxygen-dependent control of T-cell mediated immunity
Babraham Institute
19th February
Jon Gibbins Mind the gap: unexpected ways that blood cells talk to each other
Institute for Cardiovascular and Metabolic Research, University of Reading
26th February
Geert Bultynck Anti-apoptotic Bcl-2-family members and Ca2+-signaling control
Laboratory of Molecular and Cellular Signalling, KU Leuven, Belgium
5th March
James Thaventhiran TBC
MRC Toxicology Unit, University of Cambridge
12th March: Annual David James Lecture 2021
Craig M. Crews PROTAC-mediated Protein Degradation: A New Therapeutic Modality
Yale University
19th March
Susan Duty Pre-clinical exploration of neuroprotective strategies for Parkinson’s disease.
King's College
Contact Taufiq Rahman (mtur2@cam.ac.uk)
for further details
Last year
Department of Pharmacology Virtual Tea Club 2020-2021
4 pm Friday – to be held online
|
9th October |
|
|
Ewan Smith |
Driving and Controlling Nociception |
|
Department of Pharmacology, University of Cambridge |
|
|
|
|
|
16th October |
|
|
Roisin Owens |
Tissue engineering bioelectronic devices for disease modelling and drug discovery |
|
Chemical Engineering & Biotechnology, University of Cambridge |
|
|
|
|
|
23th October |
|
|
Franziska Denk |
Using public RNA sequencing data to benefit your own science – examples from peripheral neuro-immune dysfunction in pain states |
|
Wolfson Centre for Age-Related Diseases, King's College, London |
|
|
|
|
|
30th October |
|
|
Will Brackenbury |
Regulation of breast cancer progression by Nav1.5 channels |
|
University of York |
|
|
|
|
|
6nd November |
|
|
Angeliki Malliri |
Rac GTPase signalling in KRAS mutant non small cell lung cancer |
|
Cancer Research UK Manchester Institute |
|
|
|
|
|
13th November |
|
|
Stefan Feske |
Ion channels in T cell physiology: ORAI, STIM and beyond |
|
School of Medicine, New York University |
|
|
|
|
|
20th November |
|
|
Beata Wojciak- Stothard |
Kruppel-like factor 2 signalling in pulmonary arterial hypertension/or endothelial dysfunction in PAH |
|
National Heart and Lung Institute (NHLI), Imperial College, London |
|
|
|
|
|
27rd November |
|
|
Peace Atakpa |
An intimate liaison: ER-lysosome Ca2+ cross-talk |
|
Department of Pharmacology, University of Cambridge |
|
Contact Taufiq Rahman (mtur2@cam.ac.uk) for further details
Last year Seminars:
| 22Feb |
|
||||
Contact Taufiq Rahman mtur2@cam.ac.uk for further details
Department of Pharmacology Tea Club 2018-2019
4 pm Friday – Departmental Lecture Theatre
|
5th October |
|
|
Paul Miller |
Towards rational drug design against GABA-A receptors |
|
Department of Pharmacology, University of Cambridge |
|
|
|
|
|
12th October |
|
|
Sarah Flatters |
Understanding mitochondria to treat and predict chronic pain |
|
King’s College, London |
|
|
|
|
|
19th October |
|
|
Alejandra Tomas Catala |
Targeting Receptor Trafficking to Improve Beta Cell Function |
|
Department of Medicine, Imperial College, London |
|
|
|
|
|
26th October |
|
|
Stephen Tucker |
New Insights into K2P Channel Structure, function and Pharmacology |
|
Clarendron Laboratory, Dept. of Physics, University of Oxford |
|
|
|
|
|
2nd November |
|
|
David Rubinstein |
Autophagy and neurodegeneration |
|
Cambridge Institute for Medical Research, University of Cambridge |
|
|
|
|
|
9th November |
|
|
Stephen Hill |
NanoBRET approaches to study target engagement, ligand-binding kinetics andreceptor oligomerization of GPCRs and RTKs |
|
School of Life Sciences, University of Nottingham |
|
|
|
|
|
16th November |
|
|
Delphine Larrieu |
Identifying new players in nuclear envelope regulation to delay premature ageing |
|
Cambridge Institute for Medical Research, University of Cambridge |
|
|
|
|
|
23rd November |
|
|
Lucie Clapp |
Prostacyclin mimetics in the treatment of pulmonary hypertension: a revisit of cellular targets |
|
Institute of Cardiovascular Sciences, University College London |
|
Contact Taufiq Rahman (mtur2@cam.ac.uk) for further details
Case Studies series
This term also sees the start of our Case Studies series. The aim of this series is to set pharmacology in its wider context, through talks by people who use pharmacology in their work, such as pharmaceutical companies, consultants, government agencies and charities.
These talks are on Friday afternoons at 2:30pm, in the Lecture Theatre, with time for tea and cake before Tea Club. The schedule is below.
Case Studies and Tea Clubs are important parts of the course. We expect all Part II students to attend all of these talks.
